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Objective: Investigators from several studies have reported a positive relationship between low cholesterol levels
and death due to violent causes (eg, suicide and accidents), possibly mediated by depressive symptoms, aggression
or hostility, or impulsivity. We set out to establish whether middle-aged men with chronically low cholesterol
levels (#4.5 mmol/liter) have a higher risk of having depressive symptoms, according to scores on the Beck
Depression Inventory, compared with a reference group of men with cholesterol levels between 6 and 7 mmol/liter.
A similar comparison was also made for measures of anger, hostility, and impulsivity. Methods: Cholesterol
measurements were obtained as part of a population-based cholesterol screening study in 1990–1991. These levels
were remeasured in 1993–1994. Only those whose cholesterol level remained in the same range were included in
the study. Depressive symptoms were assessed by using the Beck Depression Inventory; anger, by questionnaires
based on the Spielberger Anger Expression Scale and State-Trait Anger Scale; hostility, by the Buss-Durkee Hostility
Inventory; and impulsivity, by the Eysenck and Eysenck Impulsivity Questionnaire. Results: Men with chronically
low cholesterol levels showed a consistently higher risk of having depressive symptoms (Beck Depression Inventory
score $15 or $17) than the reference group, even after adjusting for age, energy intake, alcohol use, and presence
of chronic diseases. No differences in anger, hostility, and impulsivity were observed between the two groups.
Conclusions: Men with a lower cholesterol level (#4.5 mmol/liter) have a higher prevalence of depressive
symptoms than those with a cholesterol level between 6 and 7 mmol/liter. These data may be important in the
ongoing debate on the putative association between low cholesterol levels and violent death. Key words: depressive
symptoms, serum cholesterol, men, hostility, impulsivity, anger.
BDHI 5 Buss-Durkee Hostility Inventory; BDI 5 Beck
Depression Inventory; CES-D 5 Centers for Epidemio-
logic Studies’ Depression Scale; CI 5 confidence inter-
val; IMP 5 Impulsivity Questionnaire; RR 5 relative
risk; SAQ 5 Self-Analysis Questionnaire; SECQ 5
Self-Expression and -Control Questionnaire.
INTRODUCTION
A number of investigators have reported on the re-
lationship between chronically low cholesterol levels
and death due to violent causes, notably suicide (1–6).
It has been suggested that low cholesterol levels could
lead to depression or increased risk of suicide, medi-
ated by changes in serotonin metabolism (7–10). This
mechanism would also be responsible for the associa-
tion between low cholesterol levels and increased ag-
gression observed in several human and animal stud-
ies (11–17). Impulsivity has also been associated with
suicide and aggression or hostility (18–20), but its
relationship with low cholesterol levels has not been
addressed in previous studies.
So far, two cross-sectional studies have addressed
the association between cholesterol levels and depres-
sive symptoms in older men, and both found a higher
prevalence of depressive symptoms among those with
chronically low (ie, not lowered) cholesterol levels
(21, 22). In a number of short-term experimental stud-
ies among hypercholesterolemic patients, in which
cholesterol levels were lowered by drugs or diet, a
higher mortality due to violent causes was observed in
the intervention group (23–26). These findings, how-
ever, could not be confirmed in several other studies
(27, 28). It has been suggested that depressive symp-
toms or hostility induced by lowering the cholesterol
level could be involved in this unexpected phenome-
non (29, 30). In a nonrandomized study comparing
subjects changing to a low-fat, high-carbohydrate diet
with those adhering to a traditional high-fat diet, sub-
jects changing to a low-fat, high-carbohydrate diet had
a significantly lower plasma cholesterol level and a
lower rate of depression. However, statistically signif-
icant associations between changes in plasma choles-
terol and changes in depression or aggressive hostility
were not observed (31). No studies in which the rela-
tionship between chronically low cholesterol levels
and hostility or impulsivity was investigated have
been published.
To study the relationship between cholesterol level
and depressive symptoms, anger, hostility, and impul-
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sivity, we compared two groups of middle-aged, non-
hospitalized men, one with chronically low choles-
terol levels (#4.5 mmol/liter) and one with cholesterol
levels between 6 and 7 mmol/liter.
METHODS
A cholesterol screening survey was conducted among 30,359
men, aged 40 to 70 years, in the Rotterdam, Netherlands, metropol-
itan area in 1990–1991. Nonfasting blood samples were obtained,
and cholesterol level was measured enzymatically (32). A random
sample of 310 men with a total serum cholesterol level below the
fifth centile of the cholesterol distribution (#4.5 mmol/liter) were
invited to have a second cholesterol measurement in 1993–1994
unless they used antidiabetic medication or cholesterol-lowering
drugs or had kidney disease, thyroid disease, or cancer. A second
cholesterol measurement was obtained in a total of 190 subjects. In
130 (68%) of these subjects, the cholesterol level was again #4.5
mmol/liter, and these subjects were placed in the low cholesterol
group. In addition, a sample of 401 men with initial cholesterol
levels between the 35th and 75th centiles of the cholesterol distri-
bution (between 6 and 7 mmol/liter) were invited for a second
cholesterol measurement, and blood was drawn in 235 of those
invited. The 130 (55%) subjects with a cholesterol level between 6
and 7 mmol/liter at the second measurement made up the reference
group. In both the low cholesterol and reference groups, refusal to
visit the research center for the second cholesterol measurement was
attributed to the time required for participation in the vast majority
of subjects. The fasting blood sample was also used to measure
triglyceride level. Subjects from the reference group were matched
for age (65 years) and socioeconomic background (as indicated by
postal code) to those in the low cholesterol group. Participants from
both groups completed a questionnaire requesting information on
medication use and chronic diseases and a semiquantitative food
frequency questionnaire (33) and were invited to visit the research
center. At the center, all questionnaires were checked, a medical
history was obtained, and a physical examination was conducted by
a physician. In addition, subjects were asked about any changes in
appetite over the last year and weight loss (.5% of usual body
weight) in the previous 6 months. Alcohol use was assessed by
asking subjects about the number of alcoholic drinks consumed
daily, and this number was multiplied by a standard mean alcohol
content per drink. Specific questions were asked about the preva-
lence of chronic diseases, notably pulmonary, gastrointestinal, and
cardiovascular disorders.
All participants filled out five psychological questionnaires (Ta-
ble 2): the 21-item BDI (34); a 40-item SECQ (35), based on the
Spielberger Anger Expression Scale (36); the 20-item SAQ (37),
based on the Spielberger State-Trait Anger Scale; the 75-item BDHI
(38); and the 25-item IMP, based on the work of Eysenck and Ey-
senck (39). For the BDI, two cutoff points, determined on the basis of
previous studies, were used to define depressive symptoms: $15
and $17 (40). Two distinct factors of the BDHI were studied, the
experiential (Resentment and Suspicion subscales) and the expres-
sive (Assault, Verbal and Indirect Hostility, and Irritability sub-
scales) (41–43).
Data Analysis
Mean scores on the psychological questionnaires in the two
groups were compared by applying the Mann-Whitney U test be-
cause of their nonnormal distribution. Differences of categorical
variables between the cholesterol groups were tested with the x2 test.
For questionnaire scores with established clinical cutoff points, a
dichotomous variable was created. A multivariate logistic regression
model was used, with the dichotomized questionnaire score as the
dependent variable, to adjust for potential confounders, such as
weight loss, alcohol use, and chronic diseases.
Results of all analyses are expressed as means or odds ratios (as
approximations of RRs) with 95% CIs. Associations of serum triglyc-
eride levels with scores on psychological questionnaires were also
investigated. In the analysis, the logarithm of triglyceride levels was
used to obtain a normal distribution.
RESULTS
Table 1 shows relevant general characteristics of the
study population. In total, 130 men were included in
TABLE 1. General Characteristics of Men With a Low Cholesterol Level (<4.5 mmol/liter) and a Reference Group of Men With a
Cholesterol Level Between 6 and 7 mmol/liter
Characteristic
Low Cholesterol Group
(N 5 126)
Reference Group
(N 5 129) pa
Mean SEM Mean SEM
Age, years 55.1 0.8 55.6 0.8 .69
Height, cm 176.8 0.6 176.2 0.6 .52
Weight, kg 76.4 1.1 77.4 0.9 .46
Body mass index, kg/m2 24.4 0.3 24.9 0.3 .15
Diastolic blood pressure, mm Hg 84.7 1.0 85.7 1.0 .47
Systolic blood pressure, mm Hg 134.9 1.7 136.5 1.5 .48
Serum cholesterol, mmol/liter 3.8 0.04 6.6 0.04 b
Smoking, % 37 45 .22
Caloric intake, kJ/day 11,450 300 10,970 280 .23
Alcohol intake, g/day 14.7 1.7 23.4 2.3 .003
Fat intake, g/day 112.1 3.9 105.4 3.5 .20
Recent weight loss, % 6.2 4.7 .58
Family history of depression or suicide, % 7.1 8.5 .68
a Two sided.
b Selection of groups based on cholesterol level.
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each group. Data from psychological questionnaires
were not available from four participants in the low
cholesterol group and from one in the reference group,
mainly because of language problems. Alcohol intake
in the low cholesterol group was considerably lower
than in the reference group. No significant differences
in medication use were observed.
The distribution of BDI scores is shown in Figure 1.
The relative risk of having depressive symptoms ac-
cording to the BDI is shown in Figure 2 for various
cutoff points to define depressive symptoms. Twelve
men in the low cholesterol group and three in the
reference group had scores of $15 or higher, and eight
and one, respectively, had scores of 17 or higher.
When applying the cutoff points of 15 or 17 to classify
severe depressive symptoms, the RR of having depres-
sive symptoms for those in the low cholesterol group
and those in the reference group was 4.4 (95%CI, 1.2–
16.1) and 8.7 (95%CI, 1.1–70.3), respectively. After
adjustment for differences in age, recent weight loss,
alcohol use, total energy intake, body mass index, and
presence of chronic diseases, the RRs were 7.0 (95%CI,
1.7–29.5) and 17.5 (95%CI, 1.4–224), respectively.
In this multivariate analysis, both recent weight loss
exceeding 5% (RR 5 6.8 and 18.4 for BDI cutoff points
of 15 and 17, respectively) and lower caloric intake
(per 1000 kJ; RR 5 1.4 and 2.2 for BDI cutoff points of
15 and 17, respectively) were associated with an in-
creased risk of depressive symptoms.
The mean and median scores on the SECQ and SAQ,
subscales of the BDHI, and the IMP of the two groups
are shown in Table 2. Results for these scales were
similar in the low cholesterol and reference groups, as
was the distribution of scores. In addition, categoriza-
tion of the scores on these questionnaires did not re-
veal any relevant differences between the low choles-
terol and reference groups.
The Anger-In and Anger-Out subscales of the SECQ
showed a positive association with serum triglyceride
levels (both subscales, p 5 .003). No associations were
observed between triglyceride levels and scores on the
other psychological questionnaires.
DISCUSSION
In our study among men aged 40 to 70 years, we
observed a four- to seven-fold increased risk of severe
depressive symptoms (defined as a score of $15 on the
BDI) among men with a chronically low cholesterol
level (#4.5 mmol/liter) compared with subjects in a
reference group with a cholesterol level between 6 and
7 mmol/liter. No clear differences were found in mea-
sures of anger, hostility, or impulsivity.
In a similar study (N 5 1020), Morgan et al. (21)
found a significantly higher risk of severe depressive
symptoms (BDI score $ 13) among elderly men ($70
years, N 5 394) with a low cholesterol level (,4.14
mmol/liter; mean not reported) compared with those
with a higher cholesterol level ($4.14 mmol/liter;
mean not reported).
Brown et al. (22) used the CES-D in men and women
aged 71 years or more (N 5 3939; men, N 5 1434).
Only in subjects aged 80 or more years were depressive
symptoms more common in those with a low choles-
terol level (,4.14 mmol/liter; mean not reported) than
in those with a cholesterol level of $4.14 mmol/liter
(mean not reported). However, after multivariate ad-
justment for self-reported health, physical function,
Fig. 1. Distribution of BDI scores in men with low cholesterol
levels (#4.5 mmol/liter) compared with a reference group
of men with cholesterol levels between 6 and 7 mmol/liter.
Fig. 2. Unadjusted RR of having depressive symptoms according
to the BDI (with various cutoff points) in men with low
cholesterol levels (#4.5 mmol/liter) compared with a refer-
ence group of men with cholesterol levels between 6 and 7
mmol/liter.
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and number of medications used, this relationship
weakened markedly. The BDI and the CES-D may dif-
fer in their ability to identify depression, although
Zich et al. (44) indicated that the CES-D and BDI per-
form similarly as screening instruments for depres-
sion.
Associations between low cholesterol levels and de-
pressive symptoms were observed in the higher age
categories and not in the younger age categories in the
studies by Brown et al. (22) (subjects .70 years old)
and Morgan et al. (21) (subjects $80 years old). We,
however, observed the same association in younger
age categories. More recently, both cross-sectional and
longitudinal associations between cholesterol levels
and measures of depression, hostility, and anger were
assessed in young adults, aged 23 to 35 years, by
Markowitz et al. (45). Their study included 4240 par-
ticipants, of which 1041 were white men. Depressive
symptoms were measured using the CES-D, hostility
was measured with the Cook-Medley Hostility Scale,
and anger was measured by means of the Spielberger
Trait Anxiety Scale and the Anger-In subscale of the
Spielberger Anger Expression Scale. In the cross-sec-
tional analysis, no differences in depression, hostility,
or anger scores were observed between those with a
low cholesterol level (defined as the lowest 10% in
white men, ie, #3.62 mmol/liter) and those with
higher cholesterol levels ($3.62 mmol/liter), even after
adjustments for relevant covariates. In contrast to our
study, a comparison of those with the lowest choles-
terol levels with a group with substantially higher
cholesterol levels (eg, around the 50th centile) was not
included. Importantly, this study involved a relatively
young group of men compared with prior studies, in-
cluding our own, in which an association between
lipid levels and depressive symptoms was observed.
Studies investigating associations between lipid
levels and depressive symptoms are scarce. In an in-
vestigation among Swedish women, those with a low
cholesterol level (#4.7 mmol/liter) had a statistically
significantly higher prevalence of depressive symp-
toms, even after adjustment for various other variables,
including alcohol consumption, body mass index, and
age (46).
Although the cutoff points we used to define severe
depressive symptoms (15 and 17) are frequently used
in other studies, they remain rather arbitrary. Addi-
tional analyses using other cutoff points to classify
depressive symptoms did not change our findings.
Thus, the observed association between low choles-
terol levels and depressive symptoms cannot be attrib-
uted to the few subjects with very high depression
scores. In addition, exclusion of the two participants
with the highest BDI score (both in the low cholesterol
TABLE 2. Psychological Questionnaires Used in the Study and Median and Mean Values Measured in Men With a Low Cholesterol
Level (<4.5 mmol/liter) and a Reference Group of Men With a Cholesterol Level Between 6 and 7 mmol/liter
Questionnaire
Score
Range
Median Mean
paLow Cholesterol
Group
Reference
Group
Low Cholesterol
Group
Reference
Group
BDI (depression) (34) 0–63 4 4 5.0 5.1 0.37
SECQ (anger) (35)
Control Anger-In 10–40 31 33 30.9 31.4 0.27
Control Anger-Out 10–40 33 34 31.7 32.6 0.28
Anger-In 10–40 20 19 20.1 19.9 0.60
Anger-Out 10–40 16 17 17.0 18.0 0.19
BDHI (hostility) (38)
Assault 0–20 5 6 5.4 6.0 0.43
Indirect Hostility 0–18 4 4 4.2 3.9 0.46
Irritability 0–22 8 8 7.9 7.7 0.79
Negativism 0–10 5 5 5.1 5.2 0.52
Resentment 0–16 2 2 3.6 3.2 0.58
Suspicion 0–20 6 6 6.2 5.9 0.57
Verbal Hostility 0–26 12.5 13 12.3 13.2 0.20
Guilt 0–18 9 8 9.1 8.7 0.29
SAQ (anger) (37)
Anger-State 10–40 10 10 10.9 10.6 0.27
Anger-Trait 10–40 14 13 14.7 14.8 0.87
IMP (impulsivity) (39)
Trait 11–44 17 17 17.8 17.5 0.30
State 14–56 17 17 19.0 18.5 0.38
a Nonparametric.
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group) did not appreciably alter our findings, although
the CI widened (without including 1.0).
The refusal of subjects to visit the research center for
the second cholesterol measurement is unlikely to
have introduced selection bias. First, the population
included in the cholesterol screening survey was rel-
atively healthy. Second, and more importantly, will-
ingness to participate is not related to cholesterol
level.
Alcohol intake was considerably lower in the low
cholesterol group than in the reference group. Al-
though our study design did not allow comparison of
alcohol intake between depressed and nondepressed
subjects, our findings seem to contradict the finding of
higher alcohol intake in subjects with higher depres-
sion scores reported in other studies (47).
In contrast to Morgan et al. (21) and Brown et al.
(22), we did not adjust for self-rated health or physical
functioning in the multivariate analysis. In our view,
adjustment for these factors in a multivariate analysis
can be criticized because these factors may very well
be part of the causal pathway relating cholesterol to
depressive symptoms; therefore, adjustment could di-
lute a true, existing association. However, adjustment
for the presence of chronic diseases (mainly gastroin-
testinal disorders) did not materially change the find-
ings. Food pattern and changes in food pattern as
potential confounders in the relationship between a
low cholesterol level and depressive symptoms were
not investigated in the two previous studies. Adjust-
ment for caloric intake in the analyses, although in-
cluding this variable in the analysis could equally be
criticized, did not change the association between a
low cholesterol level and depressive symptoms. More-
over, none of the participants reported major changes
in food pattern over the last 5 years.
Fowkes et al. (11) examined the relationship be-
tween serum cholesterol level, triglyceride level, and
aggression in the general population. In their study,
the Bedford-Foulds Personality Deviance Question-
naire was used. Serum triglyceride levels were posi-
tively associated with hostile acts and domineering
attitudes in men, independent of age, total and high-
density lipoprotein cholesterol, cigarette smoking, and
alcohol consumption. Our finding of a positive asso-
ciation between serum triglyceride levels and the an-
ger-in and anger-out scores on the SECQ seems to
confirm the findings of Fowkes et al., although the
Anger-In and Anger-Out subscales we used may not be
completely equivalent to the Domineering Attitude
and Hostile Acts subscales of the Bedford-Foulds Per-
sonality Deviance Questionnaire. The Anger-Trait sub-
scale of the SAQ did not show any relationship with
triglyceride levels. The mechanisms underlying the
correlation between triglyceride level and anger re-
main to be established, although some investigators
have suggested that aggressive behavior may lead to
increased triglyceride levels, mediated by enhanced
sympathetic drive (48). In another study, which inves-
tigated the relationship between lipid levels and anger
in 18- to 30-year-old men, no significant associations
between total serum cholesterol level and Anger-In
and Anger-Out subscales were observed, but a statisti-
cally significant positive correlation between high-
density lipoprotein cholesterol and scores on an An-
ger-Out subscale of the Spielberger Anger Expression
Scale (p 5 .02) was present (15). We could not repro-
duce this finding in our study (data not shown).
We did not observe clear differences in hostility and
aggression between the low cholesterol group and the
reference group. In one other study, various types of
hostility, including those measured by subscales of the
BDHI (14) and expressive hostility (ie, the sum score of
the Assault, Verbal, and Indirect Hostility subscales),
were shown to have a significant positive association
with both total cholesterol and low-density lipopro-
tein cholesterol levels. We could not confirm this find-
ing, partly because of the lack of participants with high
cholesterol levels in our study.
Although impulsivity is thought to be associated
with aggression and depression, low cholesterol levels
and impulsivity measured with the adapted version of
Eysenck and Eysenck’s (39) questionnaire were not
related in our study. We could not identify other stud-
ies assessing the association between cholesterol level
and impulsivity. This might be due to the lack of
generally used, reliable questionnaires to assess im-
pulsivity.
It is still unclear how cholesterol levels could influ-
ence the occurrence of depressive symptoms. It has
been proposed that changes in the serotonin metabo-
lism of the central nervous system, through decreased
availability of the serotonin precursor tryptophan, is
involved in this process (7, 8, 16, 17). The decreased
availability of tryptophan to the brain may be induced
by an increased binding of this amino acid to albumin,
resulting from a reduction in binding of fatty acids
(fatty acids compete with tryptophan for binding to
albumin). This reduction of binding of fatty acids to
albumin is thought to be related to low cholesterol
levels.
One should keep in mind the essential difference
between a naturally occurring low cholesterol level
and a lowered cholesterol level and the consequences
of each. A naturally occurring low cholesterol level is
considered a life-long existing feature, whereas a low-
ered cholesterol level is attained by dietary or drug
intervention. Although the prevalence of depressive
LOW SERUM CHOLESTEROL AND DEPRESSION
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symptoms is not always assessed in cholesterol-lower-
ing trials, these studies have not shown an excess of
deaths due to suicide or accidents in the study medi-
cation group (27, 28). One randomized, placebo-con-
trolled study showed no difference of effect on mood
(as measured by a shortened profile of mood states
questionnaire or reported use of psychotropic medica-
tion) between patients using simvastatin and those
receiving placebo (49).
In conclusion, we observed an increased prevalence
of severe depressive symptoms among men with a low
serum cholesterol level. This may be an important
finding in the ongoing debate concerning the putative
association between low cholesterol levels and death
due to violent causes. Future studies are needed to
reveal the mechanisms of this increased risk and to
demonstrate its causal association with chronically
low cholesterol levels.
This study was supported by Grant 28-2349 from the
Netherlands Prevention Fund and by grants from the
Rotterdam Medical Research Foundation.
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